5x Reta (30MG) (150MG Total)
54 in stock
Retatrutide (LY-3437943) – 5 × 30 MG
Retatrutide is a next-generation triple agonist of the GLP-1, GIP, and glucagon receptors. By targeting all three incretin pathways, it provides a powerful platform for research into obesity, diabetes, and metabolic regulation. This bulk pack includes five vials for extended laboratory studies.
Note: Not for human or veterinary use. For in-vitro research only.
Retatrutide (LY-3437943) – 5 × 30 MG
Retatrutide is a next-generation triple agonist of the GLP-1, GIP, and glucagon receptors. By targeting all three incretin pathways, it provides a powerful platform for research into obesity, diabetes, and metabolic regulation. This bulk pack includes five vials for extended laboratory studies.
Note: Not for human or veterinary use. For in-vitro research only.
Regulatory & Use
For laboratory research only. Not for human or veterinary use.